GranuTools enhances powder understanding by offering cutting-edge physical characterization tools. Integrating years of experience in scientific instrumentation with fundamental studies on powder ...
Matt Taylor is a senior process development associate at KBI Biopharma, where he focuses on the design, optimization, and scale-up of purification processes for biopharmaceutical manufacturing. Matt ...
Aim: To demonstrate the potential of in-line nanoparticle size measurements using the NanoFlowSizer (NFS) as a PAT method. To achieve real-time process control by establishing automated regulation of ...
Additive manufacturing (AM) offers the flexibility to produce unique, innovative designs, inaccessible with conventional production methods, and opportunities for cost-efficient bespoke manufacturing.
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle.
The quality of a drug product is determined by the manufacturing line. Preclinical assessments and clinical trials provide an indication of safety and efficacy, but it is the manufacturing process ...
This white paper offers concise, practical guidance for biopharma teams outsourcing Process Characterization (PC) to strengthen CMC packages and accelerate commercialization. Get the essential updates ...
Process validation, including process characterization, is a critical step in the successful commercialization of a new biopharmaceutical on its path to commercialization. As the program approaches ...
Automated characterization is necessary to close the loop between synthesis and discovery of new materials. Through its award-winning faculty, state-of-the-art facilities, and location, the University ...
This workshop will examine manufacturing and characterization capacity in the US for mid-scale production of sufficient quantities of emerging materials to assess the engineering utility of those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results